` Comparison: VY4, AZN - Alpha Spread

VY4
vs
AZN

Over the past 12 months, VY4 has underperformed AZN, delivering a return of +10% compared to the AZN's +32% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
VY4
AZN
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

VY4 Intrinsic Value
1.258 EUR
Overvaluation 30%
Intrinsic Value
Price
AZN Intrinsic Value
14 985.82 GBX
Undervaluation 10%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
SNDL Inc
F:VY4
1.792 EUR
AstraZeneca PLC
LSE:AZN
13 504 GBX
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
VY4, AZN

VY4
AZN
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
SNDL Inc
Revenue
AstraZeneca PLC
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
VY4, AZN

VY4
AZN
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
SNDL Inc
F:VY4
AstraZeneca PLC
LSE:AZN
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

VY4
27%
AZN
81.9%
LTM 3Y Avg 5Y Avg 10Y Avg
SNDL Inc
AstraZeneca PLC

Operating Margin

VY4
-1.2%
AZN
24.3%
LTM 3Y Avg 5Y Avg 10Y Avg
SNDL Inc
AstraZeneca PLC

Net Margin

VY4
-9.7%
AZN
16.2%
LTM 3Y Avg 5Y Avg 10Y Avg
SNDL Inc
AstraZeneca PLC

FCF Margin

VY4
6.1%
AZN
16.5%
LTM 3Y Avg 5Y Avg 10Y Avg
SNDL Inc
AstraZeneca PLC

ROE

VY4
-8%
AZN
21.7%
LTM 3Y Avg 5Y Avg 10Y Avg
SNDL Inc
AstraZeneca PLC

ROA

VY4
-6.7%
AZN
8.6%
LTM 3Y Avg 5Y Avg 10Y Avg
SNDL Inc
AstraZeneca PLC

ROIC

VY4
-1%
AZN
14.6%
LTM 3Y Avg 5Y Avg 10Y Avg
SNDL Inc
AstraZeneca PLC

ROCE

VY4
-0.9%
AZN
17.8%
LTM 3Y Avg 5Y Avg 10Y Avg
SNDL Inc
AstraZeneca PLC

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
VY4, AZN

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
VY4, AZN

Loading
VY4
AZN
Difference
www.alphaspread.com

Performance By Year
VY4, AZN

Loading
VY4
AZN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare VY4 to other stocks
Unlock Full Access to Alpha Spread
Create Free Account